Nov 5 (Reuters) - Antaria Ltd ANO.AX :
* Says "is currently investigating all avenues to restore and regain its commercial position with the licence agreement"
* Decision could see positive increases to sales in europe of approximately 10% to 20% over the next 12 - 24 months"
* Says board is currently investigating all avenues to restore and regain its commercial position with the licence agreement
* Says investigating certain aspects of Merck's performance under the agreement
* Says "seeking to resolve outstanding issues commercially with Merck (N:MRK) to improve sales"
* Source text for Eikon ID:nGLF7WwH2W